Q1 2026 Holdings
Filed 2026-05-15 | 38 holdings | $3.9B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $709.4M | 7,679,684 | 18.3% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $542.4M | 16,943,774 | 14.0% |
| Erasca Inc(ERAS) | COM | 29479A108 | $399.2M | 24,675,188 | 10.3% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $256.1M | 3,448,139 | 6.6% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $232.6M | 9,874,511 | 6.0% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $198.6M | 6,652,013 | 5.1% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $138.5M | 12,466,489 | 3.6% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $136.3M | 4,567,274 | 3.5% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $124.3M | 481,307 | 3.2% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $118.6M | 9,939,547 | 3.1% |
| Palvella Therapeutics Inc NE(PVLA) | COM | 697947109 | $110.0M | 882,400 | 2.8% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $99.9M | 4,961,108 | 2.6% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $86.6M | 1,354,852 | 2.2% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $76.4M | 1,159,879 | 2.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $65.7M | 675,686 | 1.7% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $57.2M | 3,153,082 | 1.5% |
| Savara Inc(SVRA) | COM | 805111101 | $53.1M | 9,720,852 | 1.4% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $51.1M | 728,644 | 1.3% |
| VOR Biopharma Inc(VOR) | COM NEW | 929033207 | $45.4M | 2,543,939 | 1.2% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $42.5M | 1,256,080 | 1.1% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $38.2M | 4,009,240 | 1.0% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $35.8M | 1,902,320 | 0.9% |
| Aura Biosciences Inc(AURA) | COM | 05153U107 | $34.1M | 5,100,000 | 0.9% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $32.0M | 1,438,198 | 0.8% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $30.5M | 133,333 | 0.8% |
| Lexeo Therapeutics Inc(LXEO) | COM | 52886X107 | $25.4M | 4,424,725 | 0.7% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $24.8M | 700,647 | 0.6% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $18.5M | 4,925,374 | 0.5% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $16.5M | 1,000,000 | 0.4% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $14.6M | 484,782 | 0.4% |
| Mannkind Corp(MNKD) | COM NEW | 56400P706 | $14.5M | 5,900,000 | 0.4% |
| Valneva SE(VALN) | SPONSORED ADS | 92025Y103 | $14.3M | 2,291,666 | 0.4% |
| Evolus Inc(EOLS) | COM | 30052C107 | $10.8M | 2,630,665 | 0.3% |
| Newamsterdam Pharma Company | *W EXP 99/99/999 | N62509117 | $10.0M | 500,333 | 0.3% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $9.3M | 3,796,668 | 0.2% |
| Autolus Therapeutics LTD(AUTL) | SPON ADS | 05280R100 | $6.1M | 4,447,910 | 0.2% |
| Ibio Inc(IBIO) | COM NEW | 451033708 | $3.7M | 1,953,467 | 0.1% |
| Xilio Therapeutics Inc(XLO) | COM | 98422T209 | $3.6M | 422,505 | 0.1% |